Hi.
Entering new segments is good as long as the profit margins are maintained in line with the sales.
The concalls show management also guided for sales growth but profit growth would be lower as gaining market share for new products and building the brand for OTC products.
Not a Buy/ Sell recommendation.
I prefer to stay away and read on the con calls and annual reports.
| Subscribe To Our Free Newsletter |
